CONDENSED STATEMENTS OF CASH FLOWS (Parenthetical)	3 Months Ended
	Mar. 31, 2019 USD ($)
Statement of Cash Flows [Abstract]
Discount of issuance of common stock, preferred stock and warrants for clinical trial funding commitment	$ 235,640